Sup. Figure 5: Entrectinib suppressed phosphorylation of TRK-A with G667C mutation slightly and inhibited phosphorylation of ERK transiently. from Foretinib Overcomes Entrectinib Resistance Associated with the &lt;i&gt;NTRK1&lt;/i&gt; G667C Mutation in &lt;i&gt;NTRK1&lt;/i&gt; Fusion–Positive Tumor Cells in a Brain Metastasis Model